In vitro and in vivo activity of a novel antifungal small molecule against Candida infections.
Candida is the most common fungal pathogen of humans worldwide and has become a major clinical problem because of the growing number of immunocompromised patients, who are susceptible to infection. Moreover, the number of available antifungals is limited, and antifungal-resistant Candida strains are...
Main Authors: | Sarah Sze Wah Wong, Richard Yi Tsun Kao, Kwok Yong Yuen, Yu Wang, Dan Yang, Lakshman Perera Samaranayake, Chaminda Jayampath Seneviratne |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3899067?pdf=render |
Similar Items
-
Antifungal susceptibility in serum and virulence determinants of Candida bloodstream isolates from Hong Kong
by: Chaminda Jayampath eSeneviratne, et al.
Published: (2016-02-01) -
The Proteome of Community Living <i>Candida albicans</i> Is Differentially Modulated by the Morphologic and Structural Features of the Bacterial Cohabitants
by: Thuyen Truong, et al.
Published: (2020-10-01) -
Antifungal Drug Discovery: New theories and new therapies
by: Chaminda Jayampath eSeneviratne, et al.
Published: (2016-05-01) -
Potent Antifungal Activity of Pure Compounds from Traditional Chinese Medicine Extracts against Six Oral Candida Species and the Synergy with Fluconazole against Azole-Resistant Candida albicans
by: Zhimin Yan, et al.
Published: (2012-01-01) -
Variable antifungal activity of curcumin against planktonic and biofilm phase of different candida species
by: Veena S Narayanan, et al.
Published: (2020-01-01)